Back
Centessa Pharmaceuticals PLC Quote, Financials, Valuation and Earnings
Sponsored
CNTA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
77
CNTA
Centessa Pharmaceuticals PLC
Last Price:
17.01
Seasonality Move:
7.84%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Centessa Pharmaceuticals PLC Price Quote
$17.01
-0.03 (-6.49%)
(Updated: November 23, 2024 at 5:30 AM ET)
Centessa Pharmaceuticals PLC Key Stats
Buy
77
Centessa Pharmaceuticals PLC (CNTA)
is a Buy
Day range:
$16.95 - $18.33
52-week range:
$5.58 - $18.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.5%
Volume:
843K
Avg. volume:
479.3K
1-year change:
160.55%
Market cap:
$2.2B
Revenue:
$6.9M
EPS:
$-1.52
How Much Does Centessa Pharmaceuticals PLC Make?
Data Unavailable
Is Centessa Pharmaceuticals PLC Growing As A Company?
Data Unavailable
Centessa Pharmaceuticals PLC Stock Price Performance
-
Did Centessa Pharmaceuticals PLC Stock Go Up Last Month?
Centessa Pharmaceuticals PLC share price went up by 10.22% last month -
Did CNTA's Share Price Rise Over The Last Year?
CNTA share price rose by 160.55% over the past 1 year
What Is Centessa Pharmaceuticals PLC 52-Week High & Low?
-
What Is Centessa Pharmaceuticals PLC’s 52-Week High Share Price?
Centessa Pharmaceuticals PLC has traded as high as $18.74 over the past 52 weeks -
What Is Centessa Pharmaceuticals PLC’s 52-Week Low Share Price?
Centessa Pharmaceuticals PLC has traded as low as $5.58 over the past 52 weeks
Centessa Pharmaceuticals PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Centessa Pharmaceuticals PLC?
-
How Much Debt Does Centessa Pharmaceuticals PLC Have?
Total long term debt quarterly is $0 -
How Much Cash Does Centessa Pharmaceuticals PLC Have?
Cash and short term investments quarterly total is $518.4M -
What Is Centessa Pharmaceuticals PLC’s Book Value Per Share?
Book value per share is 3.79
Is Centessa Pharmaceuticals PLC Cash Flow Positive?
-
What Is CNTA Cash Flow From Operations?
Cash flow from operations (TTM) is -$130.3M -
What Is Centessa Pharmaceuticals PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $368.2M -
What Is Centessa Pharmaceuticals PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$12M
Centessa Pharmaceuticals PLC Return On Invested Capital
Data Unavailable
Centessa Pharmaceuticals PLC Earnings Date & Stock Price
-
What Is Centessa Pharmaceuticals PLC's Stock Price Today?
A single share of CNTA can be purchased today for 17.04 -
What Is Centessa Pharmaceuticals PLC’s Stock Symbol?
Centessa Pharmaceuticals PLC trades on the nasdaq under the ticker symbol: CNTA -
When Is Centessa Pharmaceuticals PLC’s Next Earnings Date?
The next quarterly earnings date for Centessa Pharmaceuticals PLC is scheduled on March 28, 2025 -
When Is CNTA's next ex-dividend date?
Centessa Pharmaceuticals PLC's next ex-dividend date is November 24, 2024 -
How To Buy Centessa Pharmaceuticals PLC Stock?
You can buy Centessa Pharmaceuticals PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Centessa Pharmaceuticals PLC Competitors
-
Who Are Centessa Pharmaceuticals PLC's Competitors?
Below is a list of companies who compete with Centessa Pharmaceuticals PLC or are related in some way:
Centessa Pharmaceuticals PLC Dividend Yield
-
What Is CNTA Dividend Yield?
Centessa Pharmaceuticals PLC’s dividend yield currently is 0% -
What Is Centessa Pharmaceuticals PLC’s Payout Ratio?
Centessa Pharmaceuticals PLC’s payout ratio is 0% -
When Did Centessa Pharmaceuticals PLC Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is Centessa Pharmaceuticals PLC’s Dividend Per Share?
Centessa Pharmaceuticals PLC pays a dividend of $0.00 per share
Centessa Pharmaceuticals PLC Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 4.52% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 28.57 |
Upside from Last Price: | 67.67% |